BackGoodRx Holdings Overview

GoodRx Holdings Current Cash

GoodRx Holdings's current cash is $300M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$296.11M
↑ 5.26% YoYΔ $14.79M vs prior year quarter

Peer average / median

Loading

GoodRx Holdings Current Cash History

Loading

GoodRx Holdings vs. peers: Current Cash Comparison

Loading

GoodRx Holdings Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GoodRx Holdings (GDRX) FAQ

As of the most recent data (June 2026), GDRX shows a current cash of $300M. That compares with $280M in the prior-year period — up 5.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GDRX's current cash is now $300M (was $280M) — a 5.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether GoodRx Holdings is outperforming or lagging.

Tracking GDRX's current cash over time shows whether GoodRx Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $300M That compares with $280M in the prior-year period — up 5.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has GoodRx Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $300M) with ownership activity and broader fundamentals.

GoodRx Holdings's current cash is $300M; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.